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Merrill D. Birkner, Sandra E. Sinisi, and Mark J. van der Laan
Abstract
Analysis of viral strand sequence data and viral replication capacity could po-
tentially lead to biological insights regarding the replication ability of HIV-1.
Determining specific target codons on the viral strand will facilitate the manu-
facturing of target specific antiretrovirals. Various algorithmic and analysis tech-
niques can be applied to this application. We propose using multiple testing to
find codons which have significant univariate associations with replication ca-
pacity of the virus. We also propose using a data adaptive multiple regression
algorithm to obtain multiple predictions of viral replication capacity based on an
entire mutant/non-mutant sequence profile. The data set to which these techniques
were applied consists of 317 patients, each with 282 sequenced protease and re-
verse transcriptase codons. Initially, the multiple testing procedure (Pollard and
van der Laan, 2003) was applied to the individual specific viral sequence data.
A single-step multiple testing procedure method was used to control the family
wise error rate (FWER) at the five percent alpha level. Additional augmentation
multiple testing procedures were applied to control the generalized family wise er-
ror (gFWER) or the tail probability of the proportion of false positives (TPPFP).
Finally, the loss-based, cross-validated Deletion/Substitution/Addition regression
algorithm (Sinisi and van der Laan, 2004) was applied to the dataset separately.
This algorithm builds candidate estimators in the prediction of a univariate out-
come by minimizing an empirical risk, and it uses cross-validation to select fine-
tuning parameters such as: size of the regression model, maximum allowed order
of interaction of terms in the regression model, and the dimension of the vec-
tor of covariates. This algorithm also is used to measure variable importance of
the codons. Findings from these multiple analyses are consistent with biological
findings and could possibly lead to further biological knowledge regarding HIV-1
viral data.
1 Introduction
1.1 Motivation
Sequencing a virus, such as the Human Immunodeficiency Virus Type 1
(HIV-1), could potentially give further insight into the genotype-phenotype
associations of a virus. The replication ability of a virus is vital, especially in
the case of HIV, where replication is proportional to the severity of disease.
A retrovirus such as HIV-1 has a genome consisting of RNA. The virus
relies on a reverse transcriptase to perform a type of reverse transcription
of its genome from RNA into DNA for insertion and integration into the
host’s genome, otherwise known as the provirus. The retrovirus itself is a
storage place for its RNA and the reverse transcription or viral replication
takes place in the cytosol of the virus.
The reverse transcriptase and protease regions of the virus are important
areas to consider when studying the viral replication capacity of HIV-1. The
reverse transcriptase enzyme works in the capsid and is used to synthesize
the double stranded DNA from the virus’ single stranded RNA genome. This
therefore leads to the viral integration into the host’s chromosome, where it
becomes the template for RNA virus strands by the host replication machin-
ery, thus, making this region essential for viral replication. The protease is
an enzyme that breaks the peptide bonds of proteins. The virus depends
on these enzymes in its reproductive cycle, by cleaving nascent polyproteins
during viral replication.
Since these two specific regions are important in viral replication, these
areas of the virus must be analyzed when researching replication. Many an-
tiretrovirals have been manufactured to target these specific areas of the viral
strand. Antiretrovirals, known as protease inhibitors, inhibit the activity of
protease, and therefore thwart the process used by the virus to cleave vi-
ral proteins. These inhibitors therefore prevent final assembly of the HIV-1
virons. Reverse transcriptase inhibitors are another class of these antiretro-
virals. By inhibiting the activity of the reverse transcriptase, they prevent
the process of infecting the host’s cell. Lack of this enzyme prevents HIV
from building pro-viral DNA based on its RNA.
The reverse transcriptase and protease regions of a viral strand must
be sequenced when determining specific internal drug target positions. The
codon positions of these viral regions are subsequently determined. These
codon positions consist of three base pairs, and each individually code for
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a specific amino acid. Each codon position could have one of the twenty
possible amino acids.
Finally, in order to obtain a correct phenotypic assessment of the virus,
a measure of replication capacity is used. Replication capacity is the ability
of a virus to replicate in an ideal environment. This is an environment with
many cellular targets, no exogenous or endogenous inhibitors, and no immune
system responses against the virus (Barbour et al., 2002; Segal et al., 2004).
Statistical Application to Biological Data
Once sequencing the position specific codons of the viral strand and mea-
suring the replication capacity of the virus, many approaches can be used
to determine important codons which may be predictive of the replication
capacity of a virus. This data structure lends itself to both a multiple testing
procedure as well as an application for a regression based algorithm. Both
of these techniques will be applied separately to the data set to determine
codons or groups of codons which may predict replication capacity.
Previous analyses on this data set include the application of tree based
methods, in particular random forests (Segal et al., 2004). Segal et al. (2004)
found tree-structured models to be effective methods when analyzing amino
acid based viral sequence data. Their resulting trees illustrated three main
codons which were associated with viral replication capacity, which corre-
spond to the first three partitions of their tree. These codons will be discussed
in Section 3.
2 Methods
2.1 Data Structure
The HIV-1 sequence dataset consists of 317 records linking the replication
capacity (RC) with the reverse transcriptase (RT) and protease (PRO) se-
quence data from individuals participating in studies at the San Francisco
General Hospital and Gladstone Institute of Virology (Segal et al., 2004).
The protease positions 4-99 and reverse transcriptase positions 38-223 of the
viral strand are used. Each of these codon positions contains three base pairs,
which in turn codes for an amino acid. In total there are 282 positions, with
a median of 4 amino acids per position.
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At each position there are usually a majority of patients exhibiting one
amino acid as compared to the other possible amino acids at that position.
There are 282 covariate positions with the number of possible amino acids
ranging from 1-10. The outcome is a continuous measure of replication ca-
pacity ranging from 0.261 to 151.
The positions were coded as binary covariates with each codon position
corresponding to either a mutation or no mutation. The value zero repre-
sents the majority of individuals with one specific codon, and the value one
represents all of the individuals exhibiting other codons at that position,
therefore the minority of individuals. The position rt178 was somewhat am-
biguous since two of the amino acids were exhibited by a majority of the in-
dividuals. In order to accurately code this position, we referred to biological
research which indicates that the subtype B consensus amino acid at that po-
sition is I (isoleucine) and the mutations are L (leucine), M (methionine), and
V (valine) (see http://hivdb.stanford.edu/cgi-bin/RTMut.cgi). This proce-
dure of coding the positions as mutant/non-mutant has been performed in
several other analyses of HIV-1 data (Wu et al., 2003; Gonzales et al., 2003).
The natural log of the outcome of replication capacity is used in all of the
following analyses. This will allow for a more accurate interpretation of the
results, since this transformation will decrease the impact caused by the ex-
treme outliers.
We will define the observed data structure for a subject i as Oi = (Yi,Wi),
i = 1, ..., n (n = 317 individuals), where Wi = (W1i, . . . ,Wpi) is a p-vector
of explanatory variables (e.g., codon positions), and Yi is the scalar outcome
(e.g., log replication capacity).
2.2 Statistical Analysis
2.2.1 Multiple Testing Procedure
A multiple testing procedure is applied to the data set to test each codon
position with the outcome of the natural log of the replication capacity. The
testing approach creates a null distribution for the test statistics as opposed
to a null data-generating distribution. In the following section we outline
the steps used in this procedure, which includes: defining the test statistics,
null hypotheses and parameter of interest; defining the error rate which we
wish to control; defining the null distribution of the test statistics Q0 with
a resampling/bootstrap approach; and finally creating adjusted p-values for
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the M tests.
We perform simple regressions of replication capacity against the specific
codon, and estimate E(Y |Wm), where m = 1, ...,M corresponds to the M
codon positions. For each regression, the parameter of interest is the coef-
ficient of the codon, β1. The null hypothesis for each of these M tests is a
two-sided hypothesis, since we are interested in large absolute values of the
test-statistic. In this case, the null hypothesis is: H0m : β(m) = β0(m), with
β0(m) = 0, and the alternative hypothesis is H1m : β(m) 6= β0(m). The cor-
responding test-statistic is defined as: Tn(m) ≡
√
nβn(m)−β0(m)
σn(m)
, where σn(m)√
n
is the estimated standard error of βn(m). The hypothesis H0m is rejected if
Tn(m) > c(m). c(m) is selected to control a desired Type I error under an
appropriate null distribution for Tn(m), where m = 1, ...,M . In the pro-
cess of constructing the test statistics and null hypotheses, we assume that
βn(m) is an asymptotically linear estimator of β(m) (Pollard and van der
Laan, 2003).
First, we define the error rate that we wish to control. We consider three
types of Type I error rates: family-wise error rate, generalized family-wise
error rate, and tail probability of the proportion of false positives. We are
interested in controlling these three error rates, separately, at the 5-percent
α-level.
The family-wise error rate (FWER) is defined as the probability of at
least one Type I error. The FWER error rate θ(FVn) is a function of the
distribution FVn , where Vn is the number of false positives, and therefore
FWER = 1−FVn(0) = P (Vn > 0). The generalized Family-Wise Error Rate
(gFWER) is the probability of at least k + 1 Type I errors. This error rate
is defined as: gFWER(k) ≡ Pr(Vn > k) = 1 − FVn(k). When k = 0, the
gFWER is equal to the previously defined family-wise error rate, FWER.
Finally, the tail probability of the proportion of false positives (TPPFP) is
based on controlling the probability of the proportion false positives (Vn) to
the total number of rejected hypotheses (Rn), at a user supplied q and α
level. This error rate is therefore a function of the joint distribution of the
number of false positives and rejections. PFP (q) ≡ Pr(Vn/Rn > q), where
q ∈ (0, 1).
Once we define the error rates that we are interested in controlling, we
generate a null distribution. The estimated null distribution is used to derive
a common cut-off value co for the test statistics Tn(m) such that a given Type
I error rate (described above) is controlled at a specific user defined level α.
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Pollard and van der Laan (2003) proposed as the null distribution the asymp-
totic distribution of the mean-zero centered test statistics, or equivalently the
asymptotic distribution of (
√
(n)(βn(m)−β(m)) : m). This null distribution
can be estimated with the bootstrap distribution of T#n (m) =
√
nβ
#
n (m)−βn(m)
σ#n (m)
(where i.e. β#n (m) corresponds to βn(m) calculated from a bootstrap sam-
ple). They proved that with this null distribution the single-step procedures
based on the common cut-off rules for each test statistic, Tn(m), provide
asymptotic control of any Type I error rate that is a function of the distribu-
tion of the number of false positives, Vn (Dudoit et al., 2004). This approach
is generalized to general test statistics for general null hypotheses of the form
Ho,j : Po ∈Mj, where Mj is an element of a specific statistical model.
As described in detail in Pollard and van der Laan (2003) and Dudoit et al.
(2004), the Bootstrap method can be implemented as follows: Initially, one
generates B bootstrap samples, (Xb1, ...X
b
n), b = 1, ...., B. For each bootstrap
sample, an M -vector of test statistics is computed, T#n (., b) = (T
#
n (m, b)) :
m = 1, ..,M , which is arranged in an M × B matrix. This matrix will be
denoted as T#n , with rows of this matrix corresponding to the M hypotheses
and the columns correspond to the B bootstrap samples. The row means
E[Tn(m)] of the matrix T are computed, and the matrix is shifted by the
respective mean. The test statistics true distribution Qn(P ) is replaced by
a null distribution Q0, and the bootstrapped estimate of this null distri-
bution (Q0) is denoted with Q0n. After calculating the bootstrap matrix,
one can easily obtain the common cut-offs, c0, for controlling family-wise
error (FWER) control. For FWER control (k = 0), the general procedure is
summarized as the single-step maxT procedure, based on the maximum test
statistic for each column in the Q0n matrix. The estimated common cut-off
value co is the (1−α) quantile of the B-vector of maximum values, obtained
from the estimated bootstrapped distribution. This now defines a Multiple
Testing Procedure SFWE(Tn, Q0n, α).
Finally, given a Multiple Testing Procedure Sθ(Tn, Q0, α), the adjusted
p-values for each of the M tests are defined as follows. The adjusted p-value
P˜n(m) = P˜ (m,Tn, Q0), for null hypothesis H0m, is defined as:
P˜n(m) ≡ inf {α ∈ [0, 1] : Reject H0m at MTP θ-level α, given Tn}
= inf {α ∈ [0, 1] : m ∈ Sθ(Tn, Q0, α)}
We note that the adjusted p-values are defined as P˜n(m) = P˜ (m,Tn, Q0n),
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therefore based on the test statistics and null distribution. Since we are
controlling the FWER and using the maxT approach, we can calculate these
P˜ values from the distribution of the vector of maximum values.
Once we obtain the adjusted p-values controlling FWER, we used simple
augmentation techniques to control generalized family wise error (gFWER)
and the tail probability of the proportion of false positives (TPPFP)(van der
Laan et al., 2004). Therefore we will have three separate adjusted p-values
for each test, corresponding to FWER, gFWER(k), and TPPFP(q) control.
In order to control the generalized family wise error, the simple augmen-
tation procedure consists of initially ordering theM FWER adjusted p-values
from smallest to largest, P0n(On(1)) ≤ · · · ≤ P0n(On(M)), with On(m) de-
noting the indices for the ordered unadjusted p-values P0n(m). The aug-
mentation procedure used to control gFWER(k) will set the first k ordered
FWER adjusted p-values equal to 0 and the ordered FWER adjusted p-values
of m = k + 1, ...,M will result in the offset (by k) of the ordered FWER ad-
justed p-values. Therefore the k+1 ordered FWER adjusted p-value is then
equal to the first ordered FWER adjusted p-value, the k+2 ordered FWER
adjusted p-value is equal to the second ordered FWER adjusted p-value, and
so on until the M th ordered FWER adjusted p-value (equal to the M − k or-
dered FWER adjusted p-value). This process can be summarized as follows:
P˜+0n(On(m)) =
{
0, if m = 1, ..., k,
P˜n(On(m− k)), if m = k + 1, ...,M.
(1)
Additional information on this augmentation can be found in van der
Laan et al. (2004).
When controlling the tail proportion of the number of false positives
(TPPFP), the ordered FWER adjusted p-values (defined above) are again
used with a user defined q or proportion of false positives to total rejections.
The mth ordered FWER adjusted p-value is shifted by m × q, instead of
m− k as indicated in the gFWER procedure. Again, in more formal terms,
the augmentation procedure produces adjusted p-values that are defined as
(van der Laan et al., 2004):
P˜+n (On(m)) = P˜0n(On(d(1− q)me)),m = 1, . . . ,M. (2)
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2.2.2 D/S/A Algorithm
The Deletion/Substitution/Addition (D/S/A) algorithm (Sinisi and van der
Laan, 2004) is a data-adaptive regression method to predict the conditional
expectation of an outcome or response, Y , given a set of inputs or explana-
tory variables,W , whereW is a d-dimensional vector. The goal of the D/S/A
algorithm is to estimate E(Y |W ) and is completely defined by the choice of
loss function, the choice of basis functions, and the sets of deletion, substi-
tution, and addition moves. When applying the D/S/A algorithm to linear
regression, we are using the squared error loss function with tensor products
of polynomial basis functions. An example of a basis function in this context
is the three-way interaction W1W2W3.
When running the algorithm, certain fine-tuning parameters are to be
selected via cross-validation. We are selecting the size of the model (k1), i.e.,
the number of tensor products, the maximum order of interaction for each
tensor product (k2), and the dimension of the vector of covariates (k0) using
v-fold cross-validation. The algorithm splits the data, or learning set, into a
training set and validation set, and it builds estimators for k0, k1, and k2 on
the training set and evaluates, i.e., computes a cross-validated risk, for these
estimators on the validation set.
To use the D/S/A algorithm for polynomial regression, the user feeds the
data (Y,W ) and specifies a set of constraints over which to search: k0 =
{1, . . . , K0}, k1 = {1, . . . , K1}, and k2 = {1, . . . , K2}. If we want to use all
d covariates and not reduce the data, then the user can set k0 to d, a single
value representing the number of available covariates. Otherwise, we can
look at a set of possible values for k0. To reduce the number of covariates,
we compute d T -statistics corresponding to the main effects of W1, . . . ,Wd
by fitting d univariate regressions. Next, we rank these statistics, possibly
in absolute value, in decreasing order Rˆ(1), . . . , Rˆ(d) ⊂ {1, . . . , d} yielding
our ordered covariates WRˆ(1),WRˆ(2), . . . ,WRˆ(d). Then, one can input the set
(WRˆ(1), . . . ,WRˆ(k0)), of length k0, as the vector of covariates into the D/S/A
algorithm. This constraint was placed in hopes to eliminate much of the noise
and possible competition of variables in the regression models. Therefore we
will be including those variables with strong marginal associations with the
outcome.
Let k0 = {6, . . . , 10}, k1 = {1, . . . , 5}, and k2 = {2, 3} to ease in the
description of the algorithm. First, we rank our T -statistics as described
above and keep the six covariates corresponding to the six highest T -statistics
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as candidate covariates, and we begin with k2 = 2.
The algorithm starts by fitting a linear regression model with the main
term, W1 or W2 or, . . . ,Wk0 , that minimizes the squared error loss. Next, it
will begin cycling through a set of deletion, substitution, and addition moves
(Sinisi and van der Laan, 2004). At each step of the algorithm, the goal
is to find the linear combination of polynomial basis functions which best
predicts Y by minimizing the squared error loss function. The algorithm
gives preference to deletion moves, then substitution moves, then addition
moves. The algorithm will try a deletion move first, and if there is no deletion
move which improves the current best residual sum of squares (RSS) for the
fit of the same dimension, then the algorithm will try a substitution move.
If it can make a substitution move, it will go back and try another deletion
move. Otherwise, it will try an addition move. If it makes an addition move,
it goes back to trying the deletion moves. If no addition moves can be made,
then the algorithm stops. Meanwhile, the algorithm is only making moves
such that each tensor product is a main term or two-way interaction (k2 = 2),
and it is keeping track of the best model for sizes one through five (k1). Then,
we repeat this process where we allow three-way interactions (k2 = 3). This
is then repeated for seven (k0) candidate covariates, then for eight candidate
covariates, and so forth.
At the end of this process, the algorithm has produced a three-dimensional
table of cross-validated risks for k0 = 6, . . . , 10; k1 = 1, . . . , 5; and k2 = 2, 3.
We choose (k0, k1, k2) that corresponds to the minimal cross-validated risk
and call those values kˆ0, kˆ1, kˆ2. The algorithm is now run on the learning set
with k0 = kˆ0, k2 = kˆ2, and the best model of size kˆ1 is reported.
Sinisi and van der Laan (2004) compared the D/S/A algorithm to other
popular regression techniques such as forward selection, Logic Regression,
and Multivariate Adaptive Regression Splines (MARS) and found the predic-
tive power of the D/S/A algorithm to be competitive with all three methods.
2.2.3 Variable Importance Measures
In addition to reporting an optimal predictive model, the D/S/A algorithm
produces an importance measure for each variable. Sinisi and van der Laan
(2004) proposed a derivative-based method to estimate importance measures
for individual variables based on the idea of counterfactual variables in the
causality literature (van der Laan and Robins, 2003). Measures of variable
importance can assist in the identification of a subset of codons for replication
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capacity.
Let the data be n observations of (Y,W ), where Y is the outcome of
interest and W is a d-dimensional vector of covariates for which we would
like a measure of importance. Let h(W ) = E(Y |W ). Sinisi and van der
Laan (2004) explain that they are getting a sense of the importance of
variable Wj for j = 1, . . . , d by seeing what happens when Wj = wj for
a given Wj. Let hˆb represent a b-specific fit obtained by the D/S/A algo-
rithm. Given a particular b-specific fit hˆb(W ) of E(Y |W ) for b = 1, . . . , B,
let h¯jb(w) =
1
n
∑
i hˆb(W1,i, . . . ,Wj−1,i, w,Wj+1,i, . . . ,Wd,i). The importance
measure which aims to measure the “causal” effect of Wj for binary vari-
ables can be estimated as: αˆb(j) =| h¯jb(1) − h¯jb(0) |. Sinisi and van der
Laan (2004) provide a measure for continuous and general discrete variables
as well.
The final estimate of the importance measure is then a weighted average of
αˆb(j) across many b-specific fits. Various approaches for obtaining b-specific
fits hˆb can be considered. The approach we employed is to use the fits for all
models of size k1 and kˆ0, kˆ2 made by the D/S/A algorithm to estimate αˆ(j).
Let Sb ∈ {1, . . . , d} identify the subset of variables used in a b-specific fit.
Then for a given variable, its importance measure is estimated across fits as:
αˆ(j) =
B∑
b=1
αˆb(j)I(j ∈ Sb)wtb
B∑
b=1
I(j ∈ Sb)wtb
(3)
In equation (3), wt represents a weight for a particular fit. We let the
weights equal RSS/(n − p) where n represents the number of observations
and p represents the number of parameters in the fitted model.
3 Results
Table 1 presents a list of codon positions that we refer to in Tables 2 - 4
and throughout this section. In these tables pr55, for example, refers to
Kpr55G/R where we are implying that the mutant amino acids for this
position are G (glycine) or R (arginine) and the wild type amino acid is K
(lysine). When looking at our results, refer to Table 1 to determine which
amino acids are mutant or wild type.
Hosted by The Berkeley Electronic Press
Table 1: Codon Specific Amino Acids. Note: Table only includes codons
referenced in Section 3.
L pr10 I/F/R/V
K pr14 R/G
Q pr18 E/H/L/P
L pr19 A/I/Q/T/V
V pr32 G/I
E pr34 G/K/Q
P pr39 S/Q/K/T
R pr41 E/I/K
K pr43 R/T
M pr46 I/L
I pr47 L/V
I pr54 G/M/S/T/V
K pr55 G/R
L pr63 A/D/F/H/P/Q/S/T/V
H pr69 E/G/K/Q/Y
A pr71 E/I/K/L/M/T/V
G pr73 C/I/M/S/T
V pr82 A/G/I/P/S/T
L pr90 M/N/P
M rt41 A/E/G/L
D rt67 G/K/N/P/S
R rt83 K/N
K rt102 L/M/N/Q/R
D rt121 C/H/P/L/Y
I rt135 L/M/P/R/S/T/V
T rt139 E/I/K/N/R
E rt169 D/I/K/L/S
Q rt174 E/H/K/R
D rt177 E/G/N/P
I rt178 L/M/P/V/D
M rt184 E/Q/V/Y
R rt211 A/G/K/L/M/P/Q/S/T
F rt214 G/L/W
T rt215 C/D/F/G/N/S/Y
I rt202 A/K/S/T/V
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3.1 Summary of Previous Results
Sequencing the reverse transcriptase and protease positions of the HIV-1 viral
strand is an important method used to determine target areas for antiretro-
viral therapy. The reverse transcriptase and protease positions facilitate the
replication of HIV-1 virus. Sequencing these regions provides biologists with
a greater understanding of the genetic mechanism behind the resistance to
antiretroviral drugs. HIV-1 drug resistance is the generation of genetic vari-
ation in the virus. It is important not only to look at the individual effect
of these mutations on the outcome of replication capacity but also to look at
potential interaction effects between mutations.
The reverse transcriptase is a DNA polymerase that uses RNA or DNA as
its primer. These positions are responsible for producing the double stranded
DNA copy of the single strand of RNA found in the virus. This double
stranded DNA copy of the viral information can easily be inserted into the
host’s DNA, therefore facilitating replication. This area of the virus has often
been the focus of medical research, since it is the target of drugs, such as AZT,
a popular reverse transcriptase inhibitor. Reverse transcriptase inhibitors in-
hibit the polymerase reaction, which causes the manufacturing of the double
stranded DNA. Several codon position mutations are related to antiretroviral
resistance and viral replication capacity (positions rt184, rt215, rt41, rt210,
rt116, rt65, rt67, and rt69) (Shafer et al., 2001). Examples of such mutations
include rt41, where Mrt41L increases AZT resistance when present with a
Trt215Y/F mutation. A popular codon position, Mrt184V/I, partially sup-
presses the Trt215Y mediated AZT resistance. The lamivudine-resistance
mutation M184V often causes a low-level resistance to the antiretrovirals
didanosine and zalcitabine. Mrt184V also reduces replication capacity by
reducing the ability of the reverse transcriptase to process correctly. Addi-
tionally, mutations at positions of the reverse transcriptase rt41, rt184, rt215
among others have shown resistance to nucleoside analog inhibitors (Shafer
et al., 2001).
The protease is an enzyme that is responsible for the post-translation
processing of the Gag and Gag-Pol polyproteins, therefore producing the
structural proteins and enzymes of the virus. Several mutations in certain po-
sitions have been found to have an impact on resistance of the virus (codons:
pr54, pr53, pr46, pr47, pr48, pr50, pr36, pr77, pr82, pr32, pr84, pr20, pr30,
pr24, pr73, pr88, pr10, pr90, pr93, pr71, pr63) (Shafer et al., 2001). Mu-
tations at several protease cleavage sites also contribute to drug resistance.
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Examples of a protease mutation is position pr10, where Lpr10I/F/V/R is
associated with resistance to all protease inhibitors when present with an-
other mutation. Position pr90 has an impact on the substrate cleft of the
virus and L90M causes resistance to saquinavir and nelfinavir (protease in-
hibitors) when combined with various other mutations (Shafer et al., 1998).
Position Ipr54V/L/T also causes resistance to the other protease inhibitors
when present with other mutations. Mutation Gpr48V has been shown to
cause saquinavir resistance, and mutations at residues pr54 and pr82 pro-
duce resistance to indinavir and ritonavir. Mutations in position pr30 and
pr90 in the protease (Dpr30N , Lpr90M) could cause drug resistance and
also reduce the the HIV-1 viral ability to replicate in vitro. Additionally,
mutations within V pr82A, Ipr84V , and Lpr90M have been associated with
a median change in replication capacity (Barbour et al., 2002; Shafer et al.,
2001).
Finally, as previously alluded to, replication capacity is a convenient
method used to measure a virus’ ability to replicate. This measure is of-
ten used when assessing the previously mentioned mutations. The method is
described as a modification of the phenotypic drug susceptibility test (Bar-
bour et al., 2002). The patient specific gene sequences of the protease and
reverse transcriptase are inserted into a virus which contains the luciferase
gene (Barbour et al., 2002). The virus is allowed to replicate in this environ-
ment and the luciferase activity is measured and compared to the reference
virus, which are reverse transcriptase and protease sequences from a known
strain of the HIV-1 virus. The HIV-1 virus has been shown from biological
research to have a broad range of replication capacity values. These values
are useful measures when assessing various aspects of the virus (Barbour
et al., 2002).
Segal et al. (2004) applied various methods to data similar to the type
used in this article, with 336 observations involving repeated measurements
and 276 positions, and provide results given by a tree-structured method
(rpart), random forests, and logic regression. Segal et al. (2004) eliminated
6, completely conserved sites, of the 282 positions resulting in 276 positions.
For our 316 observations, with no repeated measures on a patient, we used
all 282 positions with an updated amino acid profile.
For the tree-structured method (TSM) and Random Forests (RF), Segal
et al. (2004) used the amino acid specific positions as covariates. Logic
Regression (LR) requires the covariates to be binary. Segal et al. (2004)
obtained binary predictors by creating contrast indicators for the amino acids
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at each position, resulting in 608 indicators. The optimally pruned tree
given by the TSM features one split involving rt184. In addition, Segal
et al. (2004) give a tree with further splits. The top two splits are rt184
and rt215 which correspond to primary drug resistance sites known to affect
replication capacity. Segal et al. (2004) suggest that the third split on rt178
is interesting in terms of novelty. Segal et al. (2004) provide a schematic
representation of position importance measures for the random forest with
minimal prediction error. rt184 and rt215 are the most prominent where
rt184 has an importance measure of close to 8 and rt215 has an importance
measure close to 1. Finally, the fitted LR model is given by one tree with three
leaves: rt184, rt215, and rt178. Segal et al. (2004) discuss that though rt178
is in the LR model and shown in their TSM, it is not given high importance
by RF, and the TSM achieving minimum cross-validated prediction error is
that with just one split (rt184).
3.2 Multiple Testing Procedure
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Figure 1: Controlling FWER, gFWER, and TPPFP (sorted adjusted p-
values).
Table 2 displays the adjusted p-values controlling for FWER (maxT ap-
proach) for 17 codon positions, and Figure 1 plots the sorted adjusted p-
values controlling for FWER, gFWER, and TPPFP. The FWER adjusted
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Table 2: FWER, PFP, and gFWER controlling adjusted p-values (top 17
codons)
Codon FWER (max-T) TPPFP(q=0.1) gFWER(k=5)
pr32 0.0001 0.0001 0
pr34 0.0001 0.0001 0
pr43 0.0001 0.0001 0
pr46 0.0001 0.0001 0
pr47 0.0001 0.0001 0
pr54 0.0001 0.000108 0.0001
rt184 0.00012 0.00012 0.0001
pr90 0.00012 0.000127 0.0001
rt41 0.00013 0.000131 0.0001
pr55 0.00015 0.000149 0.0001
pr82 0.0005 0.0004 0.0001
rt215 0.0005 0.0005 0.00012
pr10 0.004 0.00266 0.00013
rt121 0.01 0.008 0.00015
pr71 0.028 0.0142 0.0005
rt102 0.082 0.0465 0.0005
rt135 0.142 0.0967 0.0004
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p-values were calculated, as described in the Methods section, and two simple
augmentations were separately applied to control the TPPFP and gFWER
at a level q = 0.1 and k = 5, respectively (additional levels of q and k are
presented in Figure 1).
The gFWER augmentation, in this case, first orders the 282 FWER ad-
justed p-values and sets the first five (k) FWER adjusted p-values to 0.
The sixth ordered FWER adjusted p-value is then equal to the m − k, or
first, FWER adjusted p-value, the seventh ordered FWER adjusted p-value
is equal to the second FWER adjusted p-value, and so on until the M th or-
dered FWER adjusted p-value (equal to the 277th FWER adjusted p-value).
The TPPFP(q = 0.1) augmentation procedure first orders the 282 FWER
adjusted p-values. The mth ordered FWER adjusted p-value is shifted by
m× q, instead of m− k as outlined in the gFWER procedure.
The multiple testing procedure illustrated several codon positions that
were significant after controlling for the family wise error rate. Positions
such as rt184, rt215, rt41, pr54, pr46, pr47, pr32, pr90, pr82, pr10 and
pr71 have been confirmed in previous work as significant positions with re-
spect to replication capacity and/or antiretroviral resistance (Segal et al.,
2004; Shafer et al., 2001). The specific mutations present in our dataset also
parallel those found in previous biological research (Table 1). For example,
Ipr54V/L/T , Mpr46I, V pr32I, Lpr90M , V pr82A/T/F/S, Apr71V/T , and
Lpr10I/F/V/R are all protease positions in which mutations increase the
resistance to various protease inhibitors. Mutations at several of these posi-
tions also have an impact on the replication capacity of the virus. Reverse
transcriptase mutation at position Mrt41L increases AZT resistance when
present with Trt215Y/F . In addition,Mrt184V/I suppresses Trt215Y , thus
decreasing the AZT resistance (Shafer et al., 2001). This illustrates one of
complex mutation processes which occurs between these codons. Other codon
positions such as pr32 and pr34 and pr54 and pr55 are neighboring codons,
respectively, and therefore these mutations, in association with replication,
could potentially be of interest for future biological research.
3.3 Results from the D/S/A Algorithm
As a result of the multiple testing procedure, several codons had an adjusted
FWER p-value less than the α level of 0.05. This multiple testing proce-
dure created a subset of codons with strong marginal associations with the
outcome of replication capacity. We had initially thought of applying the
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D/S/A algorithm to this subset of codons, in hopes to eliminate the noise,
which is often present in regression models with many predictor variables.
We realized that by using this subset, created outside of the D/S/A algo-
rithm’s framework, we could be introducing bias in our final model. This is
because we are a priori predetermining the subset of variables with strong
univariate associations (not necessarily choosing these positions because of
prior biological knowledge). The bias is introduced since we would not be
cross-validating (in the D/S/A algorithm) on the full data, and therefore
only a small subset of the data, which was chosen by the multiple testing
procedure, thus not performing honest cross-validation.
Instead we reduced the number of predictor variables by allowing the
D/S/A algorithm to select k0 with cross-validation, where k0 is based on
univariate associations between a single predictor and the outcome. The
D/S/A algorithm was applied to the dataset and cross-validation was used
to select: (1) k1 and k2 and (2) k0, k1, and k2, as discussed earlier, where
k0 represents the number of initial codon variables to be used as input in
the model (dimension of vector of covariates), k1 represents the size of the
final regression model, and k2 represents the maximum order of interaction
for each tensor product. We ran the algorithm such that v = 5, in our v-fold
cross-validation scheme, k0 = 282 or k0 = {1, . . . , 282}, k1 = {1, . . . , 10}, and
k2 = {1, . . . , 4}.
The final results, using the log replication capacity as the outcome, given
by the D/S/A algorithm are displayed in Table 3. With constraints imposed
only on k1 and k2, the final fitted model consists of ten terms (kˆ1 = 10)
where the maximum order of interaction is two (kˆ2 = 2). When we imposed
three constraints, the D/S/A algorithm reduced the data to the top nine
codons (kˆ0 = 9) and produced a model with seven terms (kˆ1 = 7) where
the maximum order of interaction again is two (kˆ2 = 2). This model has
potentially important biological implications. First, rt184 is illustrated in
this model. A rt184 mutation is known from previous research (Segal et al.,
2004) to be important in the replication capacity of a virus. A mutation in
rt184 causes the virus to be unable to undergo mutagenesis to reestablish the
wild type replication kinetics, and therefore full replication does not occur.
The codon Mrt184V/I will decrease replication capacity, as confirmed by
the negative coefficient in the models. As mentioned in Section 3.2, many
of these codon mutations are biologically important with respect to viral
replication capacity and antiretroviral resistance. Protease position Lpr90M
is known to have an impact on the substrate cleft and has been shown to
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Table 3: D/S/A Algorithm: Fitted Models
k0 = 282, kˆ1 = 10, kˆ2 = 2
log(Y ) = 3.649− 0.715[pr39]− 0.848[rt184]− 3.281[pr10× pr32]− 1.737[pr18× pr19]
+1.601[rt174× rt184]− 2.128[pr69× rt184] + 0.997[pr63× rt184]
+0.870[rt184× rt202]− 1.772[rt139× rt178] + 1.320[rt169× rt184]
RSS = 148.3
kˆ0 = 9, kˆ1 = 7, kˆ2 = 2
log(Y ) = 3.648 + 2.063[pr32]− 0.817[rt184]− 0.487[rt41]− 3.206[pr32× pr43]
+1.038[rt184× rt41]− 0.978[pr43× rt41]− 2.015[pr47× rt184]
RSS = 178.7
confer resistance. The interaction terms which are found in the models could
be of biological interest. For example, V pr32I is a substrate cleft and has
been shown to have a minimal effect on resistance. Protease position pr32
is interacting with other protease positions in both reported models, which
could be of biological interest (Shafer et al., 2001).
The importance measures and proportion of times that codon was used
in all the fits made by the D/S/A algorithm for 282 codon positions are dis-
played in Table 4. Those codons not present in the table had an importance
measure of zero. These were calculated for all models fitted by the algo-
rithm for the 282 codon positions using equation (3) for binary covariates.
The results (Table 4) highlight rt139, pr32, and rt184 as important variables,
among others, within this data set. Again, as mentioned in previous sections,
a majority of the mutations illustrated in the table have important biological
implications to replication capacity and/or antiretroviral resistance, includ-
ing a mutation at position rt184.
The importance measures for Model 2, or a subset of 9 codon positions
are presented in Table 5. This model eliminates some of the noise of the
Model 1 regression by including a subset of variables with strong univariate
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Table 4: Sorted Variable Importance Measures for Model 1
Codon Position VIM Proportion
rt139 0.9439 0.31
pr32 0.8444 1.00
pr39 0.7148 0.08
rt184 0.4624 0.85
pr69 0.3749 0.54
rt174 0.3016 0.62
pr18 0.2759 0.77
rt169 0.2503 0.15
pr63 0.1843 0.46
rt202 0.1671 0.38
pr10 0.0719 0.92
pr19 0.0386 0.69
rt178 0.0368 0.23
Table 5: Sorted Variable Importance Measures for Model 2
Codon Position VIM Proportion
pr32 1.0947 1.00
rt184 0.6213 0.89
pr55 0.5759 0.05
pr47 0.3575 0.42
pr43 0.1925 0.95
pr34 0.1733 0.16
pr41 0.1702 0.79
pr90 0.1174 0.58
pr54 0 0
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associations with the outcome. Again pr32 and rt184 appear to have high
variable importance measures. In both tables, pr32 has a proportion of one
meaning that it was used in every fit. We eliminate some of the codons
which appear in Table 4, which could be noise, and pick up other potentially
important codons, such as pr47. Mutations in pr32 and pr47, from previous
research, have been shown to cause resistance to the antiretroviral Lopinavir
(LPV).
4 Discussion
As illustrated in these analyses, specific codons, or areas on the viral strand,
have important univariate associations with the log of the replication capac-
ity or predictive power in determining a virus’ replication capacity. We have
presented two methods to analyze this viral strand data. The first of which
was a multiple testing method, separately controlling FWER, gFWER and
TPPFP, which elucidated those codons with strong marginal associations
with the outcome of replication capacity. As discussed above, many of these
codons with an adjusted p-value less than 0.05, controlling FWER, have
been shown to be biologically important with replication capacity and/or
antiretroviral resistance. We then applied a data-adaptive regression algo-
rithm, the D/S/A algorithm.
It has been described earlier that Segal et al. (2004) detected rt178 with
a tree-structure method, coded by its individual amino acids, and with Logic
Regression, coded by contrast indicators, but not with Random Forests.
With our data, we coded rt178 as mutant/non-mutant, based on a priori
biological knowledge, with the non-mutant amino acid corresponding to the
subtype B consensus amino acid. We were interested in the prediction of
replication capacity, and we therefore thought that the mutant/non-mutant
coding, based on biological information, would be an appropriate coding of
our variables. When interpreting results of HIV-1 codon analyses it is always
important to keep in mind the biological information of each amino acid,
therefore its mutant/non-mutant information based on previous population
studies. We did not detect this codon as a significant codon from our multiple
testing procedures (FWER, gFWER or TPPFP). We did observe this vari-
able in an interaction term in Model 1 of the D/S/A algorithm. The variable
had a low variable importance measure in that model and did not appear
in Model 2. Our reasoning behind this is that this variable could merely
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be noise in Model 1. It has a higher proportion of mutant/non-mutants as
compared to other variables and therefore could have been chosen by the
algorithm to predict viral replication capacity, when examining all of the 282
positions. The univariate association of this variable and the outcome is not
strong and therefore was eliminated when Model 2 was run on the data.
Our multiple testing procedure did yield an adjusted p-value of less than
0.001 for rt184 and rt215. The two models displayed from the D/S/A algo-
rithm (Table 3) include rt184 and many of the covariates are included in the
top 17 codons controlling for FWER (Table 2).
The results presented in this paper will hopefully be of interest to biol-
ogists studying the HIV-1 virus. We chose to create binary predictors but
could have used discrete predictors by taking into account the specific amino
acids at each position. Previous analyses on this type of data involved re-
peated measurements for several patients. We did not have repeats in our
data, however future datasets of this kind may involve repeated measures.
The D/S/A algorithm for univariate prediction can be generalized to apply
to repeated measure outcomes.
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